DexCom

YTD

ALL

Trade DexCom 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DXCM

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE.

CEO

Jacob S. Leach

CEOJacob S. Leach

Employees

11,100

Employees11,100

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1999

Founded1999

Employees

11,100

Employees11,100

DXCM Key Statistics

Market cap

34.02B

Market cap34.02B

Price-Earnings ratio

35.94

Price-Earnings ratio35.94

Dividend yield

—

Dividend yield—

Average volume

4.04M

Average volume4.04M

High today

$92.34

High today$92.34

Low today

$89.91

Low today$89.91

Open price

$90.89

Open price$90.89

Volume

2.12M

Volume2.12M

52 Week high

$92.59

52 Week high$92.59

52 Week low

$54.11

52 Week low$54.11

Stock Snapshot

DexCom(DXCM) stock is priced at $90.14, giving the company a market capitalization of 34.02B. It carries a P/E multiple of 35.94.

On 2026-09-01, DexCom(DXCM) stock moved within a range of $89.91 to $92.34. With shares now at $90.14, the stock is trading +0.3% above its intraday low and -2.4% below the session's peak.

Trading activity shows a volume of 2.12M, compared to an average daily volume of 4.04M.

The stock's 52-week range extends from a low of $54.11 to a high of $92.59.

DXCM News

MarketWatch 6h

DexCom Inc. stock outperforms competitors despite losses on the day - MarketWatch

...

Simply Wall St 19h

G7 Momentum and Global Reach Might Change The Case For Investing In DexCom

In the past quarter, DexCom, Inc. reported that new G6 and G7 continuous glucose monitoring systems, together with broader international distribution, helped su...

Simply Wall St 6d

DexCom Stock Still Looks Undervalued Against Fair Value

DexCom stock has delivered a decline of about 35% over the past 5 years, yet a Discounted Cash Flow (DCF) intrinsic value estimate currently points to meaningfu...

Analyst ratings

81%

of 31 ratings

Buy

80.6%

Hold

19.4%

Sell

People also own

Based on the portfolios of people who own DXCM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.